Recombinant Human Glial Maturation Factor Beta Market, By Type, By Application, By Distribution, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Recombinant Human Glial Maturation Factor Beta Market size was valued at US$ 140.9 Million in 2025, expanding at a CAGR of 6.5% from 2026 to 2033.

Recombinant human glial maturation factor beta (GMFB) is a research use protein market focused on laboratory synthesized human GMFB for studying actin remodeling and neural, glial, inflammatory, regenerative, and disease mechanisms. Human GMFB is a validated 142 amino acid protein encoded by the gene GMFB on chromosome 14q22.2, which contains an ADF homology domain involved in actin filament regulation. The market is distinct from the larger growth factor markets because GMFB is primarily supplied as a specialized molecular research reagent and not as a conventional therapeutic or clinical product. As a result, demand is driven by factors such as experimental reproducibility, expression system, purity, endotoxin, sequence fidelity, and compatibility. The 2025 expansion of GMFB research into liver regeneration, diabetic retinopathy, and metabolic disease suggests that its research relevance is expanding beyond traditional neurobiological applications.

Recombinant Human Glial Maturation Factor Beta Market- Market Dynamics

Expansion of GMFB Research Beyond Conventional Neurobiology

A significant demand driver is the emerging experimental role of GMFB in disease mechanisms beyond its classical neurobiological realm. In 2025, peer-reviewed literature investigated the protein in at least three distinct indications-liver regeneration, diabetic retinopathy, and insulin resistance-linking GMFB to hepatocyte proliferation, lysosomal dysfunction, and adipocyte lipid metabolism, respectively. This diversification transforms the purchasing requirement from a neurobiological reagent into a multi-use protein amenable to cellular, tissue, and disease model experimentation. As such, suppliers compete on sequence fidelity, purity, expression platform, and documentation enabling mechanistic assay reproduction. The implication is specific: expanded GMFB biology increases the number of experimental workflows in which recombinant human protein may serve as a controlled research input.

Recombinant Human Glial Maturation Factor Beta Market- Segmentation Analysis:

The Global Recombinant Human Glial Maturation Factor Beta Market is segmented on the basis of Type, Application, Distribution, and Region.

By type, purity is a commercial indicator because GMFB experiments often depend on the presence of foreign proteins, aggregation, endotoxin, and lot-to-lot variation, especially when dealing with cellular assays of any recombinant material. Purity <95% satisfies exploratory biochemical research, in which the protein is used as a probe, while purity >=95% is more relevant to mechanistic, cell-based studies. It is evident that suppliers offer a choice between the two options due to their different applications. For instance, according to the January 2025 datasheet, Novus Biologicals provides a recombinant human GMF-beta protein with purity >98%, while other suppliers offer human GMFB with purity >=95%. Therefore, purity is now more of an experimental consideration than a catalog classification.

By application, application diversity dominates the commercial environment due to varying levels of research complexity and the range of approaches to the study of the cytoskeleton, neurobiology, inflammation, and disease rather than one specific method dominating the others. Academic institutions and research centers are more suitable for studying mechanisms, biology, and disease relationships, while diagnostic labs may perform studies related to biomarkers; biotech and pharma companies may be interested in exploring the therapeutic potential of GMFB. The research area can be justified by the 2025 NIH budget, of which the National Institute of Neurological Disorders and Stroke's budget is allocated 63 awards in the FY2025 Loan Repayment Program for Neuroscience. Therefore, the application breakdown reflects the differences in the corporate environments and research challenges addressed.

Recombinant Human Glial Maturation Factor Beta Market- Geographical Insights

North America continues to be a major market due to the combined efforts of a robust biomedical research infrastructure and a deep pool of publicly funded neurological studies. According to the NIH's FY2025 survey, there were 39,239 Research Project Grant awards in the U.S., with research project grants accounting for 80% of all research grants. While these figures do not explicitly mention GMFB, the volume of research activity indicates the potential for incorporating relevant recombinant proteins into molecular, cellular, or disease model studies. Thus, North America's primary significance for GMFB lies in the presence of numerous research organizations willing to experiment with novel biologics. For suppliers, this suggests that meeting rigorous research-grade documentation requirements, consistent lot quality control, and access to established laboratory reagent distribution channels are critical success factors.

Asia-Pacific's primary distinction is the growing number of experimental studies conducted within China and other regional research hubs that involve GMFB gene modulation. In 2025, Southern Medical University published a preprint detailing hepatocyte-specific gene knockdown experiments in zebrafish models, linking GMFB to liver regeneration and metabolic liver disease pathways. At the institutional level, South China Normal University reported 128 NSFC-funded projects in 2025, including 58 General Program grants and 57 Young Scientists Fund Class C awards. These examples illustrate the emergence of a qualified buyer base capable of adopting specialized recombinant proteins for various experimental purposes. From a regional perspective, Asia-Pacific is an important market for GMFB due to its rising capacity to generate novel experimental research needs.

Recombinant Human Glial Maturation Factor Beta Market- Competitive Landscape:

Competition is fragmented around technical specifications rather than large-scale product differentiation. Novus Biologicals stresses highly purified E. coli-derived recombinant GMF-beta, while MedChemExpress lists human GMFB products at >=95% purity; OriGene differs by both E. coli and HEK293T expression formats, and Abnova supplies GMFB-related research reagents produced through alternative expression approaches. The competitive field, therefore, spans at least three different expression approaches: bacterial, mammalian, and wheat-germ systems, thus offering buyers options according to experimental requirements. Abcam's GMFB product listing was also updated in August 2025 and provides both 100- and 500-µg formats, thus illustrating continued catalog maintenance. Competitive advantage, therefore, depends upon purity assurance, expression system suitability, formulation, applicability documentation, and reproducibility.

Recent Developments:

In July 2025, a research team from Southern Medical University published a study revealing that hepatocyte GMFB regulates liver regeneration and metabolic liver disease. Three zebrafish groups, including hepatocyte-specific GMFB knockout, GMFB overexpression, and wild-type, were used in the experiment. The experiment involved comparing the liver injury and metabolic disease models.

In August 2025, Tongji University School of Medicine researchers identified that GMFB plays a systemic role in regulating insulin resistance and studied the relationship between GMFB and CARM1 in adipocyte lipid metabolism. The research controlled the biological behaviors of GMFB in rats, mice, and human cells and discovered DS19, which could be a possible GMFB inhibitor.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RECOMBINANT HUMAN GLIAL MATURATION FACTOR BETA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific Inc. (PeproTech)
Bio-Techne Corporation (R&D Systems)
Sino Biological Inc.
Abcam plc
Novoprotein Scientific Inc.
ProSpec-Tany TechnoGene Ltd.
RayBiotech, Inc.
Creative BioMart
Cusabio Technology LLC
BPS Bioscience, Inc.
Cloud-Clone Corp.
GenScript Biotech Corporation
ACROBiosystems
OriGene Technologies, Inc.
Bio-Rad Laboratories, Inc.
Elabscience Biotechnology Inc.
Others

GLOBAL RECOMBINANT HUMAN GLIAL MATURATION FACTOR BETA MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

Purity <95%
Purity >=95%

GLOBAL RECOMBINANT HUMAN GLIAL MATURATION FACTOR BETA MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

Academic Institutions
Research Centers
Diagnostic Laboratories
Pharmaceutical & Biotech Companies
Others

GLOBAL RECOMBINANT HUMAN GLIAL MATURATION FACTOR BETA MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2020 - 2033

Distributors
Direct Sales
Online Sales/E-commerce

GLOBAL RECOMBINANT HUMAN GLIAL MATURATION FACTOR BETA MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV7438

1. Recombinant Human Glial Maturation Factor Beta Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
2.2. Competitive Insights

3. Recombinant Human Glial Maturation Factor Beta Key Market Trends

3.1. Recombinant Human Glial Maturation Factor Beta Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Recombinant Human Glial Maturation Factor Beta Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Recombinant Human Glial Maturation Factor Beta Market Opportunities
3.4. Recombinant Human Glial Maturation Factor Beta Market Future Trends

4. Recombinant Human Glial Maturation Factor Beta Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Recombinant Human Glial Maturation Factor Beta Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Recombinant Human Glial Maturation Factor Beta Market Landscape

6.1. Recombinant Human Glial Maturation Factor Beta Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Recombinant Human Glial Maturation Factor Beta Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
- 7.1.2. Purity <95%
- 7.1.3. Purity >=95%

8. Recombinant Human Glial Maturation Factor Beta Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. Academic Institutions
- 8.1.3. Research Centers
- 8.1.4. Diagnostic Laboratories
- 8.1.5. Pharmaceutical & Biotech Companies
- 8.1.6. Others

9. Recombinant Human Glial Maturation Factor Beta Market - By Distribution

9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution, 2025 & 2033 (%)
- 9.1.2. Distributors
- 9.1.3. Direct Sales
- 9.1.4. Online Sales/E-commerce

10. Recombinant Human Glial Maturation Factor Beta Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Recombinant Human Glial Maturation Factor Beta Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Recombinant Human Glial Maturation Factor Beta Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.3.16. Denmark
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.16.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.16.5. Denmark Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.3.17. Rest of Europe
  - 10.3.17.1. Overview
  - 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Recombinant Human Glial Maturation Factor Beta Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.4.15. Taiwan
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.15.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.15.5. Taiwan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.4.16. Vietnam
  - 10.4.16.1. Overview
  - 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.16.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.16.5. Vietnam Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.4.17. Rest of APAC
  - 10.4.17.1. Overview
  - 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Recombinant Human Glial Maturation Factor Beta Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Recombinant Human Glial Maturation Factor Beta Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.6.13. Iran
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.13.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.13.5. Iran Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.6.14. Qatar
  - 10.6.14.1. Overview
  - 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.14.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.14.5. Qatar Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
- 10.6.15. Rest of MEA
  - 10.6.15.1. Overview
  - 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Recombinant Human Glial Maturation Factor Beta Industry

11.1. Competitive Benchmarking
- 11.1.1. Competitive Dashboard
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Thermo Fisher Scientific Inc. (PeproTech)
- 11.2.2. Bio-Techne Corporation (R&D Systems)
- 11.2.3. Sino Biological Inc.
- 11.2.4. Abcam plc
- 11.2.5. Novoprotein Scientific Inc.
- 11.2.6. ProSpec-Tany TechnoGene Ltd.
- 11.2.7. RayBiotech, Inc.
- 11.2.8. Creative BioMart
- 11.2.9. Cusabio Technology LLC
- 11.2.10. BPS Bioscience, Inc.
- 11.2.11. Cloud-Clone Corp.
- 11.2.12. GenScript Biotech Corporation
- 11.2.13. ACROBiosystems
- 11.2.14. OriGene Technologies, Inc.
- 11.2.15. Bio-Rad Laboratories, Inc.
- 11.2.16. Elabscience Biotechnology Inc.
- 11.2.17. Others

12. 360 Degree AnalystView

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us